In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
- SELLAS plans to initiate a pivotal Phase 3 study of its WT1 vaccine in patients with acute myeloid leukemia (AML) in 2Q 2016 and a pivotal Phase 2b/3 trial in mesothelioma patients in 3Q 2016
- Philips' holistic approach to personalized cardiovascular care drives first time right diagnoses and more confident clinical decision support to help improve patient outcomes and reduce costs